Comments on NIH Prospective Exclusive License on Diabetes Treatments

Update. NIH sent us a 147 word response on November 23, 2018: NIH to KEI regarding Ovensa 23 NOV 2018. The brief reply states that “Prior to posting notices of a proposed grant of exclusive commercialization licenses, the NIH determines… Continue Reading

TRIPS Council (November 2018): Statement of South Africa on Promoting Public Health Through Competition Law and Policy

On 9 November 2018, South Africa delivered the following statement on IP and competition policy at the WTO TRIPS Council under agenda item 13 on Intellectual Property and the Public Interest: Promoting Public Health Through Competition Law and Policy (an… Continue Reading

WTO TRIPS Council: South Africa asks WTO members to share best practices to address excessive prices

UPDATE: In November 2018, South Africa notified the WTO Secretariat that Brazil and India requested to co-sponsor this submission on Promoting Public Health Through Competition Law and Policy. On 29 October 2018, the World Trade Organization (WTO) published a submission… Continue Reading

WIPO General Assembly 2018: Statement of the United States on Copyright Exceptions and Limitations

On 26 September 2018, at the 2018 WIPO General Assembly, the United States of America delivered the following intervention on Copyright Exceptions and Limitations. World Intellectual Property Organization Assemblies of the Member States September 24 to October 2, 2018 AGENDA… Continue Reading